title: Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a.
abstract: Epidermodysplasia verruciformis (EV) is an autosomal recessive disease characterized by the lifelong eruption of disseminated verrucae-like lesions. Numerous treatment modalities have been used to treat EV without benefit. Recently, retinoid and interferon therapies have been found to be of value in the treatment of EV. We present a case of EV that was treated with a combination of acitretin and interferon alfa-2a.
authors.affiliation: Department of Dermatology, Faculty of Medicine, Ankara University, Turkey.
authors.forename: R
authors.initials: R
authors.lastname: Anadolu
authors.forename: T
authors.initials: T
authors.lastname: Oskay
authors.forename: C
authors.initials: C
authors.lastname: Erdem
authors.forename: A
authors.initials: A
authors.lastname: Boyvat
authors.forename: E
authors.initials: E
authors.lastname: Terzi
authors.forename: E
authors.initials: E
authors.lastname: Gürgey
mesh_terms: D017255:Acitretin / Q000008:administration & dosage*; D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D004819:Epidermodysplasia Verruciformis / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D007641:Keratolytic Agents / Q000008:administration & dosage*; D011994:Recombinant Proteins; D012867:Skin / Q000473:pathology
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D007641:Keratolytic Agents; D011994:Recombinant Proteins; D017255:Acitretin